BrightEdge Fund Investor

BrightEdge is a Cancer Impact Fund by the American Cancer Society, accelerating the fight for a world without cancer by investing in today’s most promising innovations.

Headquarters: Atlanta, Georgia, United States
Founded Date: 2018-01-01
Investor Type: Corporate Venture Capital
Investment Stage: Early Stage Venture
Employee Number: 11-50
Number Of Exists: 3
Estimated Revenue: $9.7 million
Investors Number: 21
Industry: Finance & Banking